There are moments when the question is not what to do, but where to send the test.
The indication is clear. The case is ready.
The next step is already in mind.
But there is no clear laboratory to send it to.
At that point, the process starts to break.
The sample is delayed.
The decision is postponed.
The pathway becomes uncertain.
This is where a clear destination changes the process.
The sample follows a defined path.
The analysis follows a structured testing strategy.
The result returns to the clinician as a usable decision.
A clear laboratory destination is not a logistical detail.
It is part of the diagnostic process.
Outsourced Genomic Testing
WES, WGS, and targeted gene panels are performed within a structured clinical framework. Test selection and strategy are defined in relation to the clinical context, enabling timely and clinically relevant decisions. Access occurs through direct clinician request or coordinated referral pathways.